CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS
tafasitamab 与 CD19 的结合可提高 CART19 细胞疗法的治疗指数并减轻 CRS 的严重程度。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022018905
Sakemura, R Leo; Manriquez Roman, Claudia; Horvei, Paulina; Siegler, Elizabeth L; Girsch, James H; Sirpilla, Olivia L; Stewart, Carli M; Yun, Kun; Can, Ismail; Ogbodo, Ekene J; Adada, Mohamad M; Bezerra, Evandro D; Kankeu Fonkoua, Lionel Aurelien; Hefazi, Mehrdad; Ruff, Michael W; Kimball, Brooke L; Mai, Long K; Huynh, Truc N; Nevala, Wendy K; Ilieva, Kristina; Augsberger, Christian; Patra-Kneuer, Maria; Schanzer, Jürgen; Endell, Jan; Heitmüller, Christina; Steidl, Stefan; Parikh, Sameer A; Ding, Wei; Kay, Neil E; Nowakowski, Grzegorz S; Kenderian, Saad S